IRON SUCROSE
| Brand name | IRON SUCROSE |
|---|---|
| Active ingredient | IRON SUCROSE |
| Strength | EQ 200MG IRON/10ML (EQ 20MG IRON/ML) |
| Dosage form | INJECTABLE |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | August 2025 |
| Marketing status | RX |
| Code | Expires |
|---|---|
| CGT | February 2026 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.